You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-EGFR (phospho S1047) antibody [1H9] (ab24918)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-EGFR (phospho S1047) antibody [1H9]
See all EGFR products (87) ...

Description

Mouse monoclonal [1H9] to EGFR (phospho S1047)

Specificity

This antibody specifically recognizes EGFR phosphorylated at Serine 1047.

Tested applications

WB, ELISA, ICCmore details

Cross reactivity

Reacts with

Mouse, Dog, Human

Immunogen

Synthetic phosphopeptide (Human) corresponding to amino acid residues surrounding Serine 1047.

Positive control

The following positive control is supplied with with this antibody:- Cell lysate of 1 x 106 vanadate treated HepG2 cells. Format: Cell lysate, liquid that has been reconstituted with 100µl water and 100ul of SDS-PAGE sample buffer.

Properties

Form

Liquid

Storage instructions

Store at -20°C. Stable for 12 months at -20°C

Storage buffer

Preservative: 0.09% Sodium Azide
Constituents: 2X PBS, Polyethylene glycol, Sucrose

Concentration

Concentration information loading...

Purification notes

Thiophilic adsorption and size exclusion chromatography.

Clonality

Monoclonal

Clone number

1H9

Isotype

IgG1

  • Western blot - EGFR (phospho S1047) antibody [1H9] (ab24918)Western blot - EGFR (phospho S1047) antibody [1H9] (ab24918) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab24918 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: Use at a concentration of 0.1 µg/ml. ICC: Use at a concentration of 0.1-1.0 µg/ml. WB: Use at a concentration of 0.5 µg/ml. Predicted molecular weight: 134 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin.
Isoform 2 may act as an antagonist of EGF action.

Tissue specificity

Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers.

Involvement in disease

Defects in EGFR are associated with lung cancer (LNCR) [MIM:211980].

Sequence similarities

Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.
Contains 1 protein kinase domain.

Post-translational
modifications

Phosphorylation of Ser-695 is partial and occurs only if Thr-693 is phosphorylated.
Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occur.

Cellular localization

Secreted and Cell membrane. Endoplasmic reticulum membrane. Golgi apparatus membrane. Nucleus membrane. Endosome. In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Co-localizes with TNK2 on the endosomes.

Target information above from: UniProt accessionP00533 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • EGFR antibody
  • Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody
  • Avian erythroblastic leukemia viral (verbb) oncogene homolog antibody
  • Cell growth inhibiting protein 40 antibody
  • Cell proliferation inducing protein 61 antibody
  • EGF R antibody
  • EGFR antibody
  • EGFR_HUMAN antibody
  • Epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) antibody
  • Epidermal growth factor receptor (erythroblastic leukemia viral (v erb b) oncogene homolog avian) antibody
  • Epidermal growth factor receptor antibody
  • erbb 1 antibody
  • Erbb antibody
  • Erbb1 antibody
  • ERBB1 antibody
  • HER1 antibody
  • mENA antibody
  • Oncogene ERBB antibody
  • PIG61 antibody
  • Proto-oncogene c-ErbB-1 antibody
  • Receptor tyrosine protein kinase ErbB 1 antibody
  • Receptor tyrosine protein kinase ErbB1 antibody
  • Receptor tyrosine-protein kinase ErbB-1 antibody
  • Urogastrone antibody
  • wa2 antibody
  • Wa5 antibody
see all

Anti-EGFR (phospho S1047) antibody [1H9] images:

  Western blot - EGFR (phospho S1047) antibody [1H9] (ab24918)

Western blot - EGFR (phospho S1047) antibody [1H9] (ab24918)

All lanes : Anti-EGFR (phospho S1047) antibody [1H9] (ab24918) at 0.5 µg/ml (Serum starved HepG2 cells were treated for 15 minutes as indicated. Whole cell lysates were separated by SDS-PAGE. )

Lane 1 : Control
Lane 2 : PMA
Lane 3 : Forskolin
Lane 4 : LPA
Lane 5 : Sorbit
Lane 6 : Anisomycin
Lane 7 : Lonomycin
Lane 8 : Taxol

Lysates/proteins at 20000 cells per lane.

Secondary
A HRP-conjugated antibody
developed using the ECL technique

Predicted band size : 134 kDa


Exposure time : 30 seconds

Recommended blocking buffer CPPT: 0.5% (w/v) casein, 1% (w/v) PEG 4000, 1% (w/v) Polyvinylpyrrolidone (PVP), 0.1% Tween 20, 10mM Tris/HCl, pH 7.4, 150mM Sodium Chloride.

References for Anti-EGFR (phospho S1047) antibody [1H9] (ab24918)

ab24918 has not yet been referenced specifically in any publications.

Publishing research using ab24918? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"